Caveolin-1 expression is elevated in claudin-low mammary tumor cells

Cancer Cell International

Volumn 12, Issue , 2012, Pages

  Thompson, Devan E ^a   Siwicky, Megan D ^a   Moorehead, Roger A ^a  

^a UNIVERSITY OF GUELPH   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

CAVEOLIN 1; CYTOKERATIN 14; CYTOKERATIN 5; SOMATOMEDIN C RECEPTOR;

ANIMAL CELL; ANIMAL EXPERIMENT; ARTICLE; BREAST TUMOR; CANCER CELL CULTURE; CONTROLLED STUDY; GENOTYPE; MOUSE; NONHUMAN; PROTEIN EXPRESSION; SIGNAL TRANSDUCTION;

EID: 84857207420     PISSN: None     EISSN: 14752867     Source Type: Journal    
DOI: 10.1186/1475-2867-12-6     Document Type: Article

References (38)

1. Scherer PE, Okamoto T, Chun M, Nishimoto I, Lodish HF, Lisanti MP. Identification, sequence, and expression of caveolin-2 defines a caveolin gene family. Proc Natl Acad Sci USA 1996, 93:131-135. 10.1073/pnas.93.1.131, 40192, 8552590.
2. Kurzchalia TV, Dupree P, Parton RG, Kellner R, Virta H, Lehnert M, et al. VIP21, a 21-kD membrane protein is an integral component of trans-Golgi-network-derived transport vesicles. J Cell Biol 1992, 118:1003-1014. 10.1083/jcb.118.5.1003, 2289580, 1512286.
3. Tang Z, Scherer PE, Okamoto T, Song K, Chu C, Kohtz DS, et al. Molecular cloning of caveolin-3, a novel member of the caveolin gene family expressed predominantly in muscle. J Biol Chem 1996, 271:2255-2261. 10.1074/jbc.271.4.2255, 8567687.
4. Way M, Parton RG. M-caveolin, a muscle-specific caveolin-related protein. FEBS Lett 1995, 376:108-112. 10.1016/0014-5793(95)01256-7, 8521953.
5. Witkiewicz AK, Casimiro MC, Dasgupta A, Mercier I, Wang C, Bonuccelli G, et al. Towards a new "stromal-based" classification system for human breast cancer prognosis and therapy. Cell Cycle 2009, 8:1654-1658. 10.4161/cc.8.11.8544, 19448435.
6. Witkiewicz AK, Dasgupta A, Sotgia F, Mercier I, Pestell RG, Sabel M, et al. An absence of stromal caveolin-1 expression predicts early tumor recurrence and poor clinical outcome in human breast cancers. Am J Pathol 2009, 174:2023-2034. 10.2353/ajpath.2009.080873, 2684168, 19411448.
7. Migneco G, Whitaker-Menezes D, Chiavarina B, Castello-Cros R, Pavlides S, Pestell RG, et al. Glycolytic cancer associated fibroblasts promote breast cancer tumor growth, without a measurable increase in angiogenesis: Evidence for stromal-epithelial metabolic coupling. Cell Cycle 2010, 9:2412-2422. 10.4161/cc.9.12.11989, 20562527.
8. Pavlides S, Tsirigos A, Vera I, Flomenberg N, Frank PG, Casimiro MC, et al. Loss of stromal caveolin-1 leads to oxidative stress, mimics hypoxia and drives inflammation in the tumor microenvironment, conferring the "reverse Warburg effect": A transcriptional informatics analysis with validation. Cell Cycle 2010, 9:2201-2219. 10.4161/cc.9.11.11848, 20519932.
9. Bonuccelli G, Whitaker-Menezes D, Castello-Cros R, Pavlides S, Pestell RG, Fatatis A, et al. The reverse Warburg effect: glycolysis inhibitors prevent the tumor promoting effects of caveolin-1 deficient cancer associated fibroblasts. Cell Cycle 2010, 9:1960-1971. 10.4161/cc.9.10.11601, 20495363.
10. Pavlides S, Whitaker-Menezes D, Castello-Cros R, Flomenberg N, Witkiewicz AK, Frank PG, et al. The reverse Warburg effect: aerobic glycolysis in cancer associated fibroblasts and the tumor stroma. Cell Cycle 2009, 8:3984-4001. 10.4161/cc.8.23.10238, 19923890.
11. Martinez-Outschoorn UE, Balliet RM, Rivadeneira DB, Chiavarina B, Pavlides S, Wang C, et al. Oxidative stress in cancer associated fibroblasts drives tumor-stroma co-evolution: A new paradigm for understanding tumor metabolism, the field effect and genomic instability in cancer cells. Cell Cycle 2010, 9:3256-3276. 10.4161/cc.9.16.12553, 3041164, 20814239.
12. Martinez-Outschoorn UE, Trimmer C, Lin Z, Whitaker-Menezes D, Chiavarina B, Zhou J, et al. Autophagy in cancer associated fibroblasts promotes tumor cell survival: Role of hypoxia, HIF1 induction and NFkappaB activation in the tumor stromal microenvironment. Cell Cycle 2010, 9:3515-3533. 10.4161/cc.9.17.12928, 3047617, 20855962.
13. Pavlides S, Tsirigos A, Migneco G, Whitaker-Menezes D, Chiavarina B, Flomenberg N, et al. The autophagic tumor stroma model of cancer: Role of oxidative stress and ketone production in fueling tumor cell metabolism. Cell Cycle 2010, 9:3485-3505. 10.4161/cc.9.17.12721, 3047615, 20861672.
14. Trimmer C, Sotgia F, Whitaker-Menezes D, Balliet RM, Eaton G, Martinez-Outschoorn UE, et al. Caveolin-1 and mitochondrial SOD2 (MnSOD) function as tumor suppressors in the stromal microenvironment: a new genetically tractable model for human cancer associated fibroblasts. Cancer Biol Ther 2011, 11:383-394. 10.4161/cbt.11.4.14101, 3047109, 21150282.
15. Sager R, Sheng S, Anisowicz A, Sotiropoulou G, Zou Z, Stenman G, et al. RNA genetics of breast cancer: maspin as paradigm. Cold Spring Harb Symp Quant Biol 1994, 59:537-546. 10.1101/SQB.1994.059.01.060, 7587110.
16. Lee SW, Reimer CL, Oh P, Campbell DB, Schnitzer JE. Tumor cell growth inhibition by caveolin re-expression in human breast cancer cells. Oncogene 1998, 16:1391-1397. 10.1038/sj.onc.1201661, 9525738.
17. Heiser LM, Wang NJ, Talcott CL, Laderoute KR, Knapp M, Guan Y, et al. Integrated analysis of breast cancer cell lines reveals unique signaling pathways. Genome Biol 2009, 10:R31. 10.1186/gb-2009-10-3-r31, 2691002, 19317917.
18. Elsheikh SE, Green AR, Rakha EA, Samaka RM, Ammar AA, Powe D, et al. Caveolin 1 and Caveolin 2 are associated with breast cancer basal-like and triple-negative immunophenotype. Br J Cancer 2008, 99:327-334. 10.1038/sj.bjc.6604463, 2480981, 18612310.
19. Razani B, Lisanti MP. Caveolin-deficient mice: insights into caveolar function human disease. J Clin Invest 2001, 108:1553-1561. 201001, 11733547.
20. Yang G, Timme TL, Naruishi K, Fujita T, Fattah el MA, Cao G, et al. Mice with cav-1 gene disruption have benign stromal lesions and compromised epithelial differentiation. Exp Mol Pathol 2008, 84:131-140. 10.1016/j.yexmp.2007.08.004, 18358473.
21. Williams TM, Sotgia F, Lee H, Hassan G, Di VD, Bonuccelli G, et al. Stromal and epithelial caveolin-1 both confer a protective effect against mammary hyperplasia and tumorigenesis: Caveolin-1 antagonizes cyclin D1 function in mammary epithelial cells. Am J Pathol 2006, 169:1784-1801. 10.2353/ajpath.2006.060590, 1780215, 17071600.
22. Franks SE, Campbell CI, Barnett EF, Siwicky MD, Livingstone J, Cory S, et al. Transgenic IGF-IR overexpression induces mammary tumors with basal-like characteristics while IGF-IR independent mammary tumors express a claudin-low gene signature. Oncogene 2011,
23. Jones RA, Campbell CI, Gunther EJ, Chodosh LA, Petrik JJ, Khokha R, et al. Transgenic overexpression of IGF-IR disrupts mammary ductal morphogenesis and induces tumor formation. Oncogene 2007, 26:1636-1644. 10.1038/sj.onc.1209955, 16953219.
24. Jones RA, Campbell CI, Wood GA, Petrik JJ, Moorehead RA. Reversibility and recurrence of IGF-IR-induced mammary tumors. Oncogene 2008, 13:407-413.
25. Campbell CI, Thompson DE, Siwicky MD, Moorehead RA. Murine mammary tumor cells with a claudin-low genotype. Cancer Cell Int 2011, 11:28. 10.1186/1475-2867-11-28, 3170246, 21846397.
26. Jones RA, Campbell CI, Petrik JJ, Moorehead RA. Characterization of a novel primary mammary tumor cell line reveals that cyclin D1 is regulated by the type I insulin-like growth factor receptor. Mol Cancer Res 2008, 6:819-828. 10.1158/1541-7786.MCR-07-2157, 18505926.
27. Aslakson CJ, Miller FR. Selective events in the metastatic process defined by analysis of the sequential dissemination of subpopulations of a mouse mammary tumor. Cancer Res 1992, 52:1399-1405.
28. Chiavarina B, Whitaker-Menezes D, Migneco G, Martinez-Outschoorn UE, Pavlides S, Howell A, et al. HIF1-alpha functions as a tumor promoter in cancer associated fibroblasts, and as a tumor suppressor in breast cancer cells: Autophagy drives compartment-specific oncogenesis. Cell Cycle 2010, 9:3534-3551. 10.4161/cc.9.17.12908, 3047618, 20864819.
29. Sotgia F, Del GF, Casimiro MC, Bonuccelli G, Mercier I, Whitaker-Menezes D, et al. Caveolin-1-/- null mammary stromal fibroblasts share characteristics with human breast cancer-associated fibroblasts. Am J Pathol 2009, 174:746-761. 10.2353/ajpath.2009.080658, 2665737, 19234134.
30. Mani SA, Guo W, Liao MJ, Eaton EN, Ayyanan A, Zhou AY, et al. The epithelial-mesenchymal transition generates cells with properties of stem cells. Cell 2008, 133:704-715. 10.1016/j.cell.2008.03.027, 2728032, 18485877.
31. Hollier BG, Evans K, Mani SA. The epithelial-to-mesenchymal transition and cancer stem cells: a coalition against cancer therapies. J Mammary Gland Biol Neoplasia 2009, 14:29-43. 10.1007/s10911-009-9110-3, 19242781.
32. Herschkowitz JI, Simin K, Weigman VJ, Mikaelian I, Usary J, Hu Z, et al. Identification of conserved gene expression features between murine mammary carcinoma models and human breast tumors. Genome Biol 2007, 8:R76. 10.1186/gb-2007-8-5-r76, 1929138, 17493263.
33. Prat A, Parker JS, Karginova O, Fan C, Livasy C, Herschkowitz JI, et al. Phenotypic and molecular characterization of the claudin-low intrinsic subtype of breast cancer. Breast Cancer Res 2010, 12:R68. 10.1186/bcr2635, 3096954, 20813035.
34. Bailey KM, Liu J. Caveolin-1 up-regulation during epithelial to mesenchymal transition is mediated by focal adhesion kinase. J Biol Chem 2008, 283:13714-13724. 10.1074/jbc.M709329200, 2376249, 18332144.
35. Orlichenko L, Weller SG, Cao H, Krueger EW, Awoniyi M, Beznoussenko G, et al. Caveolae mediate growth factor-induced disassembly of adherens junctions to support tumor cell dissociation. Mol Biol Cell 2009, 20:4140-4152. 10.1091/mbc.E08-10-1043, 2754928, 19641024.
36. Savage K, Lambros MB, Robertson D, Jones RL, Jones C, Mackay A, et al. Caveolin 1 is overexpressed and amplified in a subset of basal-like and metaplastic breast carcinomas: a morphologic, ultrastructural, immunohistochemical, and in situ hybridization analysis. Clin Cancer Res 2007, 13:90-101. 10.1158/1078-0432.CCR-06-1371, 17200343.
37. Haakensen VD, Lingjaerde OC, Luders T, Riis M, Prat A, Troester MA, et al. Gene expression profiles of breast biopsies from healthy women identify a group with claudin-low features. BMC Med Genomics 2011, 4:77. 10.1186/1755-8794-4-77, 3216859, 22044755.
38. Glenney JR. Soppet D: Sequence and expression of caveolin, a protein component of caveolae plasma membrane domains phosphorylated on tyrosine in Rous sarcoma virus-transformed fibroblasts. Proc Natl Acad Sci USA 1992, 89:10517-10521. 10.1073/pnas.89.21.10517, 50370, 1279683.